Navigation Links
Alimera Sciences Reports Third Quarter 2013 Financial Results
Date:11/11/2013

regulatory and commercial updates. The conference call will be hosted by Dan Myers, president and chief executive officer, and Rick Eiswirth, chief operating officer and chief financial officer.

To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at http://www.alimerasciences.com.

A replay of the conference call will be available beginning November 11, 2013 at 7:30 p.m. ET and ending on November 17, 2013 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 92324341. A replay of the webcast will be available on the corporate website for one week, through November 17, 2013.

About Alimera Sciences, Inc.Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina.

About ILUVIEN®ILUVIEN (190 micrograms intravitreal implant in applicator) is a sustained release intravitreal implant used to treat vision impairment associated with chronic DME considered insufficiently responsive to available therapies. Each ILUVIEN implant provides a therapeutic effect of up to 36 months by delivering sustained sub-microgram levels of fluocinolone acetonide. ILUVIEN is injected in the back of the patient's eye to a position that takes advantage of the eye's natural fluid dynamics. The applicator employs a 25-gauge needle, which allows for a self-sealing wound. In the FAME™ Study, the most frequently reported adverse drug reactions included cataract development and increased ocular pressure. ILUVIEN has not been approved for sale in the U.S. ILUVIEN is approved in the United Kingdom, Germany, France
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting
2. Alimera Sciences Reports Second Quarter 2013 Financial Results
3. Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results
4. Alimera Sciences Reports First Quarter 2013 Financial Results
5. Alimera Sciences Secures $20 Million Debt Facility
6. Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results
7. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
8. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
9. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
10. Alimera Sciences Names European Management Team
11. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Research and Markets ( ... "Asia-Pacific Internal Trauma Fixation Devices Market by ... To 2019" report to their offering. ... is estimated to grow at a CAGR of ... technological advancement, rising incidences of road accidents, increasing ...
(Date:5/6/2015)... GenSpera, Inc. (OTCQB: GNSZ) announced today that the patent ... process in 17 countries and regions, including Europe ... China , Brazil and ... patent application will extend the exclusivity period for GenSpera,s core ... drug candidate, mipsagargin, until 2033. This recent patent ...
(Date:5/6/2015)... Ohio , May 6, 2015 Cardinal ... a 13 percent increase in the company,s quarterly dividend ... quarterly dividend is payable on July 15, 2015 to shareholders of ...    About Cardinal Health Headquartered in ... (NYSE: CAH ) is a $91 billion ...
Breaking Medicine Technology:Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Cardinal Health Raises Quarterly Dividend 2
... Food and Drug Administration has scheduled the third in ... academics, biotechnology companies, and those unfamiliar with the process ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ... with the Drug Information Association, will focus on the ...
... Oct. 13 Highland Capital Management, L.P. ("Highland"), ... billion of assets under management, announced today that ... --  which previously traded as (OTC Bulletin Board: ... transaction and filed documents with the SEC to ...
Cached Medicine Technology:FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010 2Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy 2Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy 3
(Date:5/6/2015)... Prime Pacific Health Innovations, the ... announce a new series of universal, one-time-use speculum ... footprint while improving treatment efficacy and saving therapists ... the world’s first waste hose designed specifically for ... claims the company’s president, Mr. Delmar Vogel. , ...
(Date:5/6/2015)... May 06, 2015 “ SideChef ” was featured ... look at the latest and coolest applications on the market for ... technology expert, conducted the app review and shared with viewers how ... the day when to be a good navigator people had to ... and now everyone is a master navigator. Well what if people ...
(Date:5/6/2015)... 2015 vcfo, a specialized consulting firm ... operational support to optimize business performance and productivity, announced ... and Michael Scheaffer. Both Lynch and Scheaffer have more ... , “We are delighted to add Jack and ... “Leveraging their background in financial management and leadership, Mike ...
(Date:5/6/2015)... 2015 Healthcare jobs platform, ... launching in mid-February. The company connects hospitals, home-health, and ... experience in the industry. Likewise, job seekers are able ... Kyle Johnson, CTO, unique traffic to the site is ... "Each new job posting brings targeted, interested candidates to ...
(Date:5/6/2015)... 06, 2015 The Alliance for ... regenerative medicine and advanced therapies community, today announced ... offering an in-depth look at sector trends and ... , The report is available online here ... data points, available here . , Using ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... aiding certain patients with the blood cancer , , WEDNESDAY, ... of the once-banned drug thalidomide for patients with myeloma ... as it is to science: Don,t judge results too ... therapy regimens increased the odds of a complete remission, ...
... Counseling for All Combat Veterans, WASHINGTON, July 9 ... in 39 additional,communities across the country where the Department ... 2009., "Community-based Vet Centers -- already in all ... health program," said Dr. James B. Peake,Secretary of Veterans ...
... conditions cause significant decrease in body,s ability to repair ... News) -- Diabetes and being over- or underweight can ... the conclusion of two reports to be presented July ... of Human Reproduction & Embryology, in Barcelona, Spain. , ...
... Inc.,(NYSE and SWX: ZMH) announced today its second quarter ... over the Internet on,Thursday, July 24, 2008, at 8:00 ... will be made available at 7:00 a.m. the,morning of ... be accessed via Zimmer,s Investor Relations,website at http://investor.zimmer.com ...
... the elderly and people without health insurance especially vulnerable, ... Every summer, an estimated 6,200 Americans are hospitalized for ... who were hospitalized died, according to the latest ... Healthcare Research and Quality. , Severe heat exposure, ...
... neighborhoods to advance benefits of selecting Michigan ... July 9 The Associated Food &,Petroleum Dealers (AFPD) ... to make fresh, local produce more readily,available to Metro ... program called "Buy Local, Eat Fresh.", "We have ...
Cached Medicine News:Health News:Thalidomide Continues to Show Benefits Against Myeloma 2Health News:Thalidomide Continues to Show Benefits Against Myeloma 3Health News:VA Vet Centers Coming to 39 Communities 2Health News:Diabetes, Weight Tied to Male Infertility 2Health News:Heat Exposure a Dangerous Summer Threat 2Health News:Select Michigan and Associated Food & Petroleum Dealers Launch 'Buy Local, Eat Fresh' 2Health News:Select Michigan and Associated Food & Petroleum Dealers Launch 'Buy Local, Eat Fresh' 3
... exact enhanced corneal thickness measuring algorithm used ... by the OHTS investigators. The IOP correction ... new backlit LCD character displays OD and ... IOP correction calculation and allows easy visibility ...
The Medmont C100 Colour Vision Tester is an electronic colour vision screening device which is used to rapidly detect red/green colour vision deficiencies. Its high sensitivity provides a positive in...
... E300 Corneal Topographer has applications ... clinical procedures including Radial Keratotomy, ... Contact Lens Fitting. Based on ... the E300 analyses an accurate ...
... The first Open Bore MR ,Siemens has ... 70 cm bore, a very short 125 cm ... create something very revolutionary: Open Bore MR. And ... imaging matrix). A unique Siemens technology, which means ...
Medicine Products: